These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 17174228

  • 1. Racial differences in the characteristics of patients admitted for acute decompensated heart failure and their relation to outcomes: results from the OPTIME-CHF trial.
    Echols MR, Felker GM, Thomas KL, Pieper KS, Garg J, Cuffe MS, Gheorghiade M, Califf RM, O'Connor CM.
    J Card Fail; 2006 Dec; 12(9):684-8. PubMed ID: 17174228
    [Abstract] [Full Text] [Related]

  • 2. Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study.
    Felker GM, Benza RL, Chandler AB, Leimberger JD, Cuffe MS, Califf RM, Gheorghiade M, O'Connor CM, OPTIME-CHF Investigators.
    J Am Coll Cardiol; 2003 Mar 19; 41(6):997-1003. PubMed ID: 12651048
    [Abstract] [Full Text] [Related]

  • 3. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study.
    Klein L, O'Connor CM, Leimberger JD, Gattis-Stough W, Piña IL, Felker GM, Adams KF, Califf RM, Gheorghiade M, OPTIME-CHF Investigators.
    Circulation; 2005 May 17; 111(19):2454-60. PubMed ID: 15867182
    [Abstract] [Full Text] [Related]

  • 4. Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT.
    Thackray S, Witte K, Clark AL, Cleland JG.
    Eur J Heart Fail; 2000 Jun 17; 2(2):209-12. PubMed ID: 10856736
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM, Crouch MA, Carroll NV, Oinonen MJ.
    Pharmacotherapy; 2006 Aug 17; 26(8):1078-85. PubMed ID: 16863484
    [Abstract] [Full Text] [Related]

  • 7. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.
    Cuffe MS, Califf RM, Adams KF, Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M, Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators.
    JAMA; 2002 Mar 27; 287(12):1541-7. PubMed ID: 11911756
    [Abstract] [Full Text] [Related]

  • 8. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
    Klein L, Massie BM, Leimberger JD, O'Connor CM, Piña IL, Adams KF, Califf RM, Gheorghiade M, OPTIME-CHF Investigators.
    Circ Heart Fail; 2008 May 27; 1(1):25-33. PubMed ID: 19808267
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure.
    King JB, Shah RU, Sainski-Nguyen A, Biskupiak J, Munger MA, Bress AP.
    Pharmacotherapy; 2017 Jun 27; 37(6):662-672. PubMed ID: 28475215
    [Abstract] [Full Text] [Related]

  • 14. Comparing the effects of milrinone and olprinone in patients with congestive heart failure.
    Dobashi S, Watanabe I, Nakanishi R, Hisatake S, Kiuchi S, Kabuki T, Oka T, Fujii T, Ikeda T.
    Heart Vessels; 2020 Jun 27; 35(6):776-785. PubMed ID: 31865433
    [Abstract] [Full Text] [Related]

  • 15. Race, quality of care, and outcomes of elderly patients hospitalized with heart failure.
    Rathore SS, Foody JM, Wang Y, Smith GL, Herrin J, Masoudi FA, Wolfe P, Havranek EP, Ordin DL, Krumholz HM.
    JAMA; 2003 May 21; 289(19):2517-24. PubMed ID: 12759323
    [Abstract] [Full Text] [Related]

  • 16. OPTIME in CHF trial: rethinking the use of inotropes in the management of worsening chronic heart failure resulting in hospitalization.
    Gheorghiade M, Gattis WA, Klein L.
    Eur J Heart Fail; 2003 Jan 21; 5(1):9-12. PubMed ID: 12559209
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risk stratification after hospitalization for decompensated heart failure.
    Felker GM, Leimberger JD, Califf RM, Cuffe MS, Massie BM, Adams KF, Gheorghiade M, O'Connor CM.
    J Card Fail; 2004 Dec 21; 10(6):460-6. PubMed ID: 15599835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.